{"title": "Essential Oils and Post COVID-19 Fatigue - Full Text View - ClinicalTrials.gov", "author": null, "url": "https://clinicaltrials.gov/ct2/show/NCT04980573", "hostname": "clinicaltrials.gov", "description": "Essential Oils and Post COVID-19 Fatigue - Full Text View.", "sitename": "ClinicalTrials.gov", "date": "2021-07-28", "cleaned_text": "Essential Oils and Post COVID-19 Fatigue | The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our | |ClinicalTrials.gov Identifier: NCT04980573| | | Recruitment Status : Completed First Posted : July 28, 2021 Last Update Posted : January 24, 2022 - Study Details [Tabular View](/ct2/show/record/NCT04980573) [No Aromatherapy Fatigue: A Randomized, Double Blind, Controlled Trial| |Actual Study Start Date :||August 2021| |Actual Primary Date :||November Participants receive a bottle of plant-based oil to inhale twice daily for 14 days. | Other: Aromatherapy | The aromatherapy intervention consists of inhaling a fragrant oil extracted from citrus peels, plant resins, and leaves. | Placebo Comparator: Placebo | Participants receive a bottle of inert oil to inhale twice daily for 14 days. | Other: Placebo | The placebo intervention consists of inhaling an oil extracted from inert plant matter. - Change from baseline on the Multidimensional Fatigue Symptom Inventory (MFSI) at day 14. [ Time Frame: Baseline and Day 14 ]The MFSI is a validated, 83 question scale measuring fatigue levels across ten domains. Each question is scored from 0-5 on a Likert scale, with higher scores indicating higher levels of fatigue. - Change from baseline to day 14 on the Patient Health Questionnaire (PHQ-9) [ Time Frame: Baseline and Day 14 ]This survey includes 9 questions regarding levels of depression. Each question is scored from 0-3 on a Likert scale, with higher scores indicating higher levels of depression. Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, [Learn About Clinical Studies.](/ct2/about-studies/learn) |Ages Eligible for Study:||19 Years to for Study:||All| Based Eligibility:||Yes| |Gender Eligibility Description:||Eligibility is based on self-representation of gender and is restricted to women.| |Accepts Healthy Volunteers:||Yes| Inclusion Criteria: - Age 19-49 - Lives in the United States - Otherwise Healthy - COVID-19 Diagnosis between December 1, 2020 and March 31, 2021 - Decreased energy or fatigue at a level that was not present prior to the diagnosis Exclusion Criteria: - Positive COVID-19 test any time before December 1, 2020 - Positive COVID-19 test any time after March 31, 2021 - COVID vaccine of any type scheduled during the intervention period or the week prior to the start of the study - Allergy to any of the ingredients - Pregnant, trying to conceive, or breastfeeding - Regular smokers in the home - Abnormal pulmonary function - Chest pain - Recurring headaches - Uncontrolled hypertension - Chronic Fatigue Syndrome diagnosis - Persistent fatigue prior to COVID-19 diagnosis - Hypothyroidism To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor. Please refer to this study by its ClinicalTrials.gov identifier (NCT a U.S. FDA-regulated Device Product:||No| | essential oils | aromatherapy energy | COVID-19 | Fatigue Pneumonia, Viral Pneumonia Respiratory Tract Infections Infections Virus Diseases | Coronavirus Infections | Coronaviridae Infections Nidovirales Infections RNA Virus Infections Lung Diseases Respiratory Tract Diseases "}